$1.30 -0.09 (%) Prima Biomed Shs Sponsored American Deposit Receipt Repr 30 Shs - NASDAQ

Jul. 2, 2015 | 04:00 PM

Partner Headlines

  1. Benzinga's Top #PreMarket Losers

    Benzinga | Jun. 4, 2015 | 08:28AM EST
  2. Benzinga's Top #PreMarket Gainers

    Benzinga | Jun. 3, 2015 | 08:11AM EST
  3. Benzinga's Top #PreMarket Gainers

    Benzinga | May. 29, 2015 | 08:11AM EST
  4. Benzinga's Top #PreMarket Losers

    Benzinga | May. 28, 2015 | 08:19AM EST
  5. Prima BioMed Receives NASDAQ Notice of Bid Price Deficiency

    GuruFocus | Dec. 29, 2014 | 11:03AM EST
  6. Prima BioMed Announces Immutep's IMP321 Patent Application Receives Canadian Patent Office ...

    GuruFocus | Dec. 22, 2014 | 11:02AM EST
  7. Prima BioMed Completes Immutep Acquisition

    GuruFocus | Dec. 17, 2014 | 11:03AM EST
  8. Prima Biomed Enhances CVac Manufacturing and Logistics Capability

    GuruFocus | Dec. 5, 2014 | 11:02AM EST
  9. CVac Demonstrates Overall Survival Benefit in Second Remission Ovarian Cancer

    GuruFocus | Nov. 6, 2014 | 11:06AM EST
  10. Prima BioMed to Host Conference Call & Webcast to Discuss Acquisition of Immutep

    GuruFocus | Oct. 21, 2014 | 16:04PM EST
  11. Morning Market Movers

    Benzinga | Jul. 16, 2014 | 09:44AM EST
  12. Morning Market Movers

    Benzinga | Nov. 25, 2013 | 10:00AM EST
  13. Stocks Hitting 52-Week Lows

    Benzinga | Sep. 25, 2013 | 10:12AM EST
  14. Stocks Hitting 52-Week Lows

    Benzinga | Sep. 18, 2013 | 10:11AM EST
  15. Morning Market Losers

    Benzinga | Sep. 18, 2013 | 10:06AM EST
  16. Prima BioMed's "CANVAS" Clinical Trial Approved to Start in Korea

    Benzinga | Aug. 14, 2013 | 07:10AM EST
  17. Benzinga's Top Pre-Market Losers

    Benzinga | Aug. 5, 2013 | 08:17AM EST
  18. Morning Market Losers

    Benzinga | Jun. 21, 2012 | 03:49AM EST
  19. From Earlier: Prima BioMed CEO to Step Dowm

    Benzinga | May. 24, 2012 | 01:43AM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!